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The oral administration of hyaluronic acid has been shown to improve skin health. This study aimed at utilizing 
ultrasound treatment to enhance the production of hyaluronic acid by lactobacilli. Among the 16 strains of lactobacilli 
screened, a higher production of hyaluronic acid (P<0.05) was observed from seven strains namely, Lactobacillus 
casei BT 2113, Lactobacillus casei BT 1268, Lactobacillus casei BT 8633, Lactobacillus casei FTDC 8033, 
Lactobacillus acidophilus FTDC 1231, Lactobacillus gasseri FTDC 8131 and Lactobacillus rhamnosus FTDC 
8313. Upon ultrasonic treatment, hyaluronic acid concentration increased significantly (P<0.05) in all the seven 
strains studied. The use of ultrasonication at 100% amplitude increased the hyaluronic acid content (P<0.05) up to 
51.6 % with concentrations ranging from 0.262 mg ml–1 to 0.385 mg ml–1, while an amplitude of 20% yielded a lower 
increase ranging from 0.227 mg ml–1 to 0.310 mg ml–1. Increasing duration of ultrasonic treatment (from 1 min to 3 
min) also significantly (P<0.05) improved the concentration of hyaluronic acid in some strains. Our data demonstrated 
that a sub-lethal physical treatment, such as ultrasonication, can be applied to increase the membrane permeability 
of lactobacilli cells and subsequently increase the release of bioactive metabolites. 
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Lactobacilli have long been known to exhibit functional characteristics typically associated 
with probiotic bacteria ranging from gut health to metabolic diseases (Liong et al., 2007), 
attributed to their abilities to produce bioactive metabolites such as acids and enzymes (Liong 
& SHaH, 2005; Yeo & Liong, 2010). In this case, probiotics can be defined as ‘living 
microorganisms, which present a benign efficacy in terms of physical well-being to the host 
when administered in sufficient quantity’ (HoLzapfeL & SCHiLLinger, 2002). Recent evidences 
have shown an apparent rise in researches on lactobacilli detailing a host of other ancillary 
benefits. In a clinical study carried out by KaLLioMaKi and co-workers (2001), it was 
discovered that Lactobacillus GG possesses a high efficacy in preventing atopic eczema, a 
form of dermatitis amongst high risk children. As such, the dermal benefits associated with 
lactobacilli is an interesting aspect to investigate, considering that arCK and co-workers 
(2010) postulated that lactobacilli have the potential to regulate dermal health from preventing 
skin disorders to mitigating skin ageing. This notion was further corroborated by pinTo and 
co-workers (2011), who found that Lactobacillus plantarum produces bioactive compounds 
that can aid tissue regeneration. In a way, the bioactive compounds produced by lactobacilli 
can enhance the bodily response to improve skin health, and have been demonstrated to be 
especially favourable in wound healing (BraCHKova et al., 2011). 
Hyaluronic acid (HA) is one such dermal bioactive constituent being produced by 
lactobacilli. There are numerous therapeutic advantages of HA as detailed by priCe and co-
workers (2007), such as in the field of ophthalmic surgery, aesthetic augmentation, epithelial 
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regeneration and drug delivery. fujiKawa (2008) demonstrated that the oral administration of 
HA at more than 120 mg per day improved skin dryness, itchiness, erosion and exfoliation. 
In another randomized, double-blind, placebo controlled study involving 40 healthy subjects 
with joint discomfort, oral supplementation of 80 mg per day of HA for 90 days significantly 
improved joint mechanics and muscle function, thus attenuating risk factors and alleviating 
symptoms of knee osteoarthritis (MarTinez-puig et al., 2012). Conventionally, HA is extracted 
from avian and bovine sources, animal-derived sources pose a high risk of cross-species 
infection with viruses and pathogens as well as potential contamination, which can affect the 
quality of the end product (CHong et al., 2005). Microbial fermentation may be a preferred 
alternative, considering the lower production cost. It has been reported for the first time in 
2009 that HA is produced in milk broth through fermentation by a putative probiotic strain 
Streptococcus thermophilus YIT2084 (Izawa et al., 2009). In a more recent study, it is reported 
that certain strains of lactobacilli, such as L. rhamnosus FTDC 8313 and L. gasseri FTDC 
8131, were also capable of producing HA at concentrations of more than 1 g l–1 when 
cultivated in skimmed milk, suggesting its potential use in dermatological field (Lew et al., 
2013). Hyaluronic acid is produced intracellularly and excreted to the extracellular matrix via 
transportation across the plasma membrane; hence, the permeability of the cell membrane 
plays a crucial part in facilitating transfers of dermal bioactive metabolites extracellularly. 
Mild and sub-lethal physical treatments, such as ultrasonication, has been reported to increase 
membrane permeability (Ewe et al., 2012; Lye et al., 2012) and transport of metabolites 
across microbial membranes. The effects of ultrasound on cells are, however, dependent on 
the strength and frequency of waves, cell wall structure and treatment environment 
(TaBaTaBaie & MorTazavi, 2008). Although extensive research has been carried out on the 
many therapeutic benefits displayed by lactobacilli, not much emphasis has been given on 
dermatological aspects and the production of dermal bioactives, such as HA. We thus 
hypothesized that the yield of HA obtained from lactobacilli can be increased upon the 
application of sub-lethal ultrasonic treatments. 
1. Materials and methods
1.1.  Bacterial cultures
Lactobacillus casei BT 2113, L. casei BT 1311, L. casei BT 1268, L. casei BT 8633, L. casei 
FTDC 8033, L. casei BT 314, L. acidophilus FTDC 0291, L. acidophilus FTDC 1733, 
L. acidophilus FTDC 1231, L. bulgaricus FTDC 8011, L. bulgaricus FTDC 1211, L. gasseri 
FTDC 8131, L. gasseri CHO 220, L. rhamnosus FTDC 8313, L. fermentum FTDC 8219 and 
L. fermentum FTDC 8312 were obtained from the Culture Collection Centre of Bioprocess 
Technology Division, Universiti Sains Malaysia (Penang, Malaysia). The stock cultures were 
stored at –20 °C in 40% (v/v) sterile glycerol. The strains were activated in sterile de Man, 
Rogosa and Sharpe (MRS) broth (Hi-Media, Mumbai, India) for three consecutive times 
using 10% (v/v) inoculum and incubated at 37 °C for 24 h ahead of use. 
1.2. Determination of hyaluronic acid
Ten millilitres of sterile MRS broth was inoculated with 10% (v/v) inoculum and incubated 
at 37 °C for 20 h. Standardization was carried out on the fermentation broth by way of the 
absorbance to 0.3 at 600 nm using a UV-Vis spectrophotometer (Shimadzu, Kyoto, Japan). It 
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was then centrifuged at 10,000 g for 15 min at 25 °C. The supernatant was collected and 
stored at –20 °C prior to analyses. Hyaluronic acid concentrations were determined using the 
cetyltrimethylammonium bromide (CTAB) turbidimetric method (CHen & Wang, 2009). The 
sample was first mixed with 2.5 volumes of absolute ethanol and rested at 4 °C for an hour. 
The sample was then centrifuged at 10 000 g for 15 min at 4 °C and the sediment was 
dissolved in five volumes of distilled deionised water. CTAB reagent was prepared by 
dissolving 2.5 g CTAB (Sigma-Aldrich) in 100 ml of 0.2 M NaCl solution. One millilitre of 
HA standard and sample were mixed gently with 2.0 ml of CTAB reagent and allowed to rest 
for 10 min before measuring the absorbance at 400 nm using a UV-Vis spectrophotometer 
(Shimadzu).
1.3. Physical treatment via ultrasonication
Activated cultures were subjected to ultrasonication using an Ultrasonic Homogenizer 
(Sartorius Stedim Biotech, Goettingen, Germany) with a frequency of 30 kHz and nominal 
power of 115 W cm–2. The treatment intensities were adjusted to three different levels, namely 
20%, 60% and 100%. In all treatments, the tip of the sonotrode (at 80 mm in length and 3 mm 
in diameter) was positioned at the same position, that is immersed at a 10 mm depth of the 
10 ml culture medium. The samples were then ultrasonicated at three different durations 
namely, 1, 2 and 3 min at 25 °C and followed by cooling at 4 °C for 15 min. Untreated cells 
were used as control.
1.4. Scanning electron microscopy
The cell pellet was fixed with the McDowell Trump fixative agent (4%, v/v formaldehyde, 
Sigma-Aldrich; 1%, v/v glutaraldehyde, Sigma-Aldrich) and 1% (w/v) osmium tetroxide 
(Sigma-Aldrich). Following that, the pellet was dehydrated alternately with a series of 
ethanol and hexamethyldisilazane (Supelco, Bellefonte, PA, USA). The dried cells were 
mounted onto a scanning electron microscopy specimen stub, coated with gold in a Sputter 
coater (Polaran, Walford, UK) and examined under a scanning electron microscope (Leo 
Supra, Oberkochen, Germany).
1.5. Determination of viability
Viability (log CFU ml–1) of the treated and control cells were evaluated via the pour plate 
method in MRS agar. The plated MRS agar was incubated at 37 °C for 48 hours. 
1.6. Statistical analysis 
Data analysis was performed using SPSS Inc. software (Version 20.0) (Chicago, IL, USA). 
One-way and two-way analysis of variance (ANOVA) were used to evaluate the significant 
differences between sample means, with significance level at α=0.05. Mean comparisons 
were assessed by Tukey’s test and all data presented were mean values obtained from three 
separate runs. P-values were stipulated for both amplitude and time to indicate the general 
inclination of the factors studied on the response variables with the respective statistical 
significance.
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2. Results and discussion
2.1. Screening of Lactobacillus sp. for production of hyaluronic acid
All the 16 strains of lactobacilli studied were able to produce varying concentrations of HA. 
A higher concentration of HA was detected from seven out of the 16 strains of lactobacilli 
studied, namely L. casei BT 2113, L. casei BT 1268, L. casei BT 8633, L. casei FTDC 8033, 
L. acidophilus FTDC 1231, L. gasseri FTDC 8131 and L. rhamnosus FTDC 8313 (P<0.05), 
with concentrations ranging from 0.236 mg ml–1 to 0.303 mg ml–1. These strains were selected 
for the subsequent evaluation using ultrasonication. Considering that HA is produced 
intracellularly before being transported into the extracellular matrix (Izawa et al., 2009), the 
permeability of the cellular membrane would be a significant barrier in the transportation of 
HA across the membrane. 
Hyaluronic acid is postulated to be released extracellularly because of its gel-like 
characteristics, which aid microorganisms in adherence to existing environment as well as 
providing protection against reactive oxides (YaMada & KawaSaKi, 2005). Extracellular HA 
lends its gel-like properties to the microbial colonies formed with the slimy translucent outer 
layer (CHong et al., 2005). Not all strains of lactobacilli screened exhibit similar HA producing 
capabilities. The capability of lactobacilli to excrete HA is uniquely strain dependent, some 
species do not produce HA, while others have been found to be excellent producers of HA 
(Lew & Liong, 2013). 
2.2. Effect of ultrasonication on the concentration of hyaluronic acid
In this present study, all treated strains showed a significant increase (P<0.05) in the 
concentration of HA upon ultrasonic treatment (Table 1). Hyaluronic acid in the extracellular 
matrix is an important aspect for an improved and uncomplicated recovery of the bioactive 
metabolite from the fermentation media. Correspondingly, the use of ultrasonication at 100% 
amplitude increased (P<0.05) the production of HA up to 51.6% with concentrations ranging 
from 0.262 mg ml–1 to 0.385 mg ml–1. On the other hand, an amplitude of 20% contributed to 
a lower increase in HA content, with concentrations ranging from 0.227 mg ml–1 to 0.310 mg 
ml–1. Increasing the intensity of the ultrasonic treatment also increased the production of HA 
in all strains studied (P<0.05). The duration of ultrasonic treatment also significantly (P<0.05) 
affected the concentration of HA. Cells treated at 20% amplitude for 1 min showed little 
changes in the concentration of HA. However, in strains, such as L. casei BT 1268, L. casei 
BT 2113, L. gasseri FTDC 8131, L. rhamnosus FTDC 8313 and L. casei BT 8633, treatment 
for 3 min produced a significant increase in HA concentration compared to shorter durations 
studied (P<0.05).
Ultrasonication has long been used as a sub-lethal physical treatment to enhance 
membrane permeabilisation allowing for improved mass transfer across the membrane (Yeo 
& Liong, 2011; Lye et al., 2012). Results obtained from the current study justified the 
significant increase of HA concentration after ultrasonic treatment. This may be attributed to 
the increase in cross membrane transfer of HA from inside the cell to the extracellular matrix. 
We postulate that the cross-membrane movement that was previously hindered by the plasma 
membrane has been enhanced upon ultrasonication. Evidently from the results obtained, by 
increasing the intensity of the ultrasonic treatment, the concentration of HA increased 
proportionally as well.
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2.3. Scanning electron microscopy
Scanning electron microscopy was performed to inspect the effect of ultrasonic treatment on 
the morphology of the lactobacilli cells (Fig. 1). Untreated cells (control; Fig. 1A) showed a 
Table 1. Concentration of hyaluronic acid in extracellular extracts of control and ultrasound-treated lactobacilli 
cultured in MRS broth for 20 h at 37 °C
Amplitude (%) Extracellular hyaluronic acid concentration  
(mg ml–1 of MRS)
Statistical significance of effect: 
P
Time (min)
1 2 3 A T A x T
L. acidophilus FTDC 1231 Controla=0.280±0.003 <0.001 0.116 0.003
20 0.290±0.001 0.310±0.002 0.283±0.015
60 0.284±0.001 0.299±0.002 0.291±0.002
100 0.357±0.010 0.385±0.012 0.357±0.017
L. casei BT 1268 Controla=0.258±0.005 <0.001 < 0.001 <0.001
20 0.265±0.003 0.266±0.002 0.273±0.002
60 0.272±0.002 0.277±0.004 0.285±0.003
100 0.300±0.001 0.335±0.009 0.330±0.002
L. casei BT 2113 Controla=0.225±0.003 <0.001 < 0.001 <0.001
20 0.227±0.001 0.227±0.001 0.231±0.001
60 0.236±0.001 0.245±0.003 0.252±0.001
100 0.262±0.002 0.300±0.001 0.341±0.001
L. casei FTDC 8033 Controla=0.243±0.001 <0.001 <0.001 <0.001
20 0.249±0.001 0.255±0.001 0.260±0.001
60 0.268±0.001 0.277±0.002 0.287±0.001
100 0.295±0.002 0.305±0.003 0.294±0.001
L. gasseri FTDC 8131 Controla=0.242±0.002 <0.001 <0.001 0.722
20 0.248±0.001 0.252±0.001 0.257±0.001
60 0.267±0.001 0.271±0.001 0.276±0.001
100 0.284±0.002 0.293±0.001 0.294±0.001
L. rhamnosus FTDC 8313 Controla=0.257±0.001 <0.001 <0.001 <0.001
20 0.258±0.002 0.266±0.002 0.268±0.002
60 0.300±0.001 0.297±0.001 0.319±0.002
100 0.297±0.003 0.334±0.002 0.358±0.003
L. casei BT 8633 Controla=0.269±0.002 <0.001 <0.001 0.008
20 0.269±0.001 0.267±0.002 0.276±0.002
60 0.282±0.002 0.290±0.001 0.299±0.002
100 0.339±0.001 0.385±0.001 0.360±0.002
Results are expressed as mean±standard deviation. The values are means of repeated measurements from three 
separate runs (n=3).
a Control: untreated cells
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smoother and intact plasma membrane surface without any pronounced physical effect, while 
ultrasonic treated cells at 100% amplitude for 3 min showed the formation of pores in the cell 
membrane (Fig. 1B). It can be suggested that the formation of pores on the membrane of the 
lactobacilli cells allowed the uncomplicated channelling of HA into the extracellular matrix. 
This view was supported by the concept of ultrasonication, where mechanical waves produced 
from the tip of the sonotrode could stimulate acoustic cavitation, hence the appearance of 
temporary, non-specific pores on the cellular membrane (Ewe et al., 2012). It has been 
reported that cells were able to return to their impermeable state immediately after ultrasound 
exposure with pore opening that last within milliseconds to seconds (MeHier-HuMBerT et al., 
2005). However, the temporarily formed pores did not alter the growth of cells during 
fermentation, and cells from the subsequent passage showed intact membrane morphology 
(data not shown), supporting the fact that the treatment was sub-lethal and cells resumed their 
normal growth. 
A                                                                               B
Fig. 1. Scanning electron micrographs of Lactobacillus acidophilus FTDC 1231 without treatment (A) and 
lactobacilli treated with ultrasound at 100% amplitude for 3 min (B).  
Circles indicate ruptured cells and cells with pores
2.4. Viability of Lactobacillus sp. immediately upon treatment 
The effect of ultrasonic treatment on the viability of lactobacilli was strain dependent 
(Table 2). Ultrasonic treatment at 100% amplitude showed detrimental effects on the growth 
of cells especially L. casei BT 8633, compared to the control and cells treated at other lower 
intensities. Some strains showed a significant increase (P<0.05) in viability at 100% 
amplitude, such as L. gasseri FTDC 8131 and L. rhamnosus FTDC 8313. At 20% amplitude, 
the viability of L. gasseri FTDC 8131 was significantly increased (P<0.05) in contrast to the 
control. In addition, increasing the duration of the ultrasonic treatment also resulted in an 
increase (P<0.05) in viability of cells and this was most prevalent for L. rhamnosus FTDC 
8313. In contrast, L. casei BT 8633 showed a lower (P<0.05) viability immediately after 
treatment at 100% amplitude for 3 min compared to the control. When lactobacilli were 
treated at lower amplitude of 20% for 3 min, viability was higher (P<0.05) than that of 
control, and this was most prevalent for L. casei BT 1268, L. casei FTDC 8033, L. rhamnosus 
330 HOR et al.: PRODUCTION OF HYALURONIC ACID BY LACTOBACILLI
Acta Alimentaria 43, 2014
FTDC 8313 and L. gasseri FTDC 8131. All treated cells were inoculated into a fresh batch of 
medium and showed an increase in growth after fermentation (growth was comparable within 
strains; data not shown). 
Table 2. Viability of control and ultrasound-treated lactobacilli after fermentation  
in sterile MRS broth for 20 h at 37 °C
Amplitude (%) Viability (log CFU ml-1) Statistical significance of effect
Time (min)
1 2 3 A T A x T
L. acidophilus FTDC 1231 Controla=7.21±0.14 <0.001 <0.001 0.008
20 7.45±0.17 7.35±0.21 7.15±0.14
60 7.22±0.27 7.20±0.08 7.11±0.10
100 7.23±0.12 7.01±0.14 7.23±0.09
L. casei BT 1268 Controla=7.12±0.18 0.035 0.008 <0.001
20 6.88±0.06 6.96±0.15 7.20±0.08
60 6.93±0.11 7.08±0.03 7.05±0.11
100 7.19±0.18 7.01±0.09 6.98±0.03
L. casei BT 2113 Controla=7.16±0.05  <0.001 <0.001 0.424
20 6.67±0.21 7.06±0.06 6.98±0.25
60 6.90±0.03 7.35±0.12 7.05±0.15
100 6.87±0.13 7.19±0.15 7.01±0.08
L. casei FTDC 8033 Controla=6.97±0.11 0.027 0.138 0.399
20 6.88±0.05 7.21±0.10 7.18±0.09
60 7.01±0.14 7.22±0.17 7.27±0.21
100 6.93±0.09 7.17±0.25 7.04±0.15
L. gasseri FTDC 8131 Controla=6.82±0.16 <0.001 <0.001 0.722
20 6.91±0.11 6.93±0.08 6.89±0.11
60 6.95±0.18 7.04±0.12 7.17±0.22
100 7.10±0.21 7.11±0.26 7.09±0.09
L. rhamnosus FTDC 8313 Controla=7.17±0.25  <0.001 <0.001 <0.001
20 7.32±0.27 6.98±0.12 7.26±0.15
60 7.35±0.22 7.10±0.05 7.18±0.10
100 7.32±0.28 7.19±0.18 7.29±0.19
L. casei BT 8633 Controla=7.28±0.19  <0.001 <0.001 0.047
20 7.25±0.21  7.31±0.05 7.22±0.13  
60 7.10±0.16  7.08±0.06  7.11±0.09  
100 7.12±0.25  7.15±0.12 7.12±0.16  
Results are expressed as mean±standard deviation. The values are means of repeated measurements from three 
separate runs (n=3).
a Control: untreated cells
331HOR et al.: PRODUCTION OF HYALURONIC ACID BY LACTOBACILLI
Acta Alimentaria 43, 2014
In this study, the ultrasonication parameters used were sublethal, thus would not have 
terminated or killed all cells. Even though there are many benefits in utilising ultrasonication 
to obtain higher yields of HA, inactivation of the released bioactive compounds and cell lysis 
may nevertheless occur (LaTeef et al., 2007). This explains the detrimental effects of 
ultrasonic treatment at 100% amplitude on the growth of certain lactobacilli strains studied. 
Ultrasonication has been reported to cause increased structural changes to the cells leading to 
the interference of regular cellular functions, such as nutrient transport and cell division as 
well as the disruption of the phospholipid membrane (Yeo & Liong, 2011). However, for 
certain strains, such as L. gasseri FTDC 8131 and L. rhamnosus FTDC 8313, cell viability 
increased after treatment at 100% amplitude. Our results also showed that a higher viability 
was observed upon treatment at higher amplitudes and longer durations. ewe and co-workers 
(2012) mentioned that since lactobacilli exhibit aggregating properties in nature, 
ultrasonication often de-clump bacterial clusters thereby increasing the number of viable cell 
counts upon fermentation. 
3. Conclusions
In conclusion, the permeability and fluidity of the membrane play significant role in 
influencing both extracellular HA concentration and cellular viability. Upon ultrasonic 
treatment, HA concentration increased significantly (P<0.05) in all strains of lactobacilli 
studied. 
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